Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02025894

Acronym

ONCOCIP

Enrollment

3032

Registered

2014-01-01

Start date

2010-06-30

Completion date

2015-03-31

Last updated

2017-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

neoplastic solid tumour, PCVC, thromboembolic complications, infectious complications, risk factors

Brief summary

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with a neoplastic solid tumour with an indication for insertion of a PCVC.

Exclusion criteria

* Haematological neoplasm pathology, PCVC removal scheduled within 2 weeks of insertion, * Therapeutic doses of anticoagulants required at inclusion, * PCVC inserted by the femoral vein

Design outcomes

Primary

Measure	Time frame
Thromboembolic complications:	one year
Locoregional or disseminated infectious complications:	one year

Secondary

Measure	Time frame
Medical and economic consequences of these complications	one year

Countries

France

Outcome results